Injective (INJ) is a layer-one blockchain designed to support the development of decentralized finance (DeFi) applications, including decentralized spot and derivatives exchanges, prediction markets, and lending protocols. It offers foundational financial infrastructure like a fully decentralized on-chain order book, aiming to support various financial markets such as spot, perpetual, futures, and options—all executed fully on-chain. Injective is compatible with Ethereum, IBC-enabled blockchains, and non-EVM chains like Solana. Built using the Cosmos SDK, it employs a Tendermint-based Proof-of-Stake consensus mechanism, which strives to deliver instant transaction finality and high performance.

Injective utilizes a Tendermint-based Proof-of-Stake consensus mechanism, enabling fast transaction finality and maintaining high network performance. It incorporates a decentralized cross-chain bridging infrastructure that supports compatibility with Ethereum, IBC-enabled chains, and non-EVM blockchains like Solana. Injective's core exchange module features an advanced on-chain order book and matching engine for spot, perpetual, futures, and options markets. It aims to reduce Miner-Extractable Value (MEV) through frequent batch auctions and strives to offer zero gas fees for users. Smart contracts are powered by CosmWasm, facilitating seamless multi-chain transactions and enabling complex DeFi applications.

Injective seeks to serve as a foundation for diverse DeFi applications, offering essential infrastructure like an on-chain order book for building decentralized exchanges, prediction markets, and lending protocols. The INJ token is central to the platform, used for protocol governance, securing the network through staking, incentivizing developers, and capturing value from decentralized applications. Injective aims to facilitate a wide range of trading and yield-generating activities, supporting interoperability across multiple layer-one blockchains, including Cosmos and Ethereum, thereby broadening the scope of DeFi opportunities.

Injective was developed by Injective Labs, a research and development firm co-founded by Eric Chen, who brings expertise in blockchain protocols and traditional finance. Albert Chon, the CTO, is a Stanford graduate and former software engineer at Amazon, known for pioneering an Ethereum standard adopted by major projects. The Injective ecosystem aims to encompass over 100 projects and has grown to include more than 150,000 community members worldwide. The project has received backing from various investors, supporting its mission to expand decentralized finance infrastructure.

我们实时将 Injective 更新为 SGD 货币。通过 Coinbase 获取最新 Injective 价格。

Injective的当前市值为 S$13.84亿。高市值意味着该资产在市场上的价值很高。

Injective的历史最高价位是 S$67.44。这是Injective自推出以来的最高价格。

在过去 24 小时内，Injective的交易量为 S$7585.99万。

与Injective具有相似市值的资产包括Four, Celestia, SPX6900和许多其他资产。要查看完整列表，请参阅我们的可比市值资产。

Injective的当前流通供应量是 9997万。

Injective在 Coinbase 上的可交易资产中排名 97。受欢迎程度目前基于相对市值。

目前，有 94% 的 Coinbase 用户正在购买Injective。换句话说，94% 的 Coinbase 客户在过去 24 小时内通过交易增加了他们在Injective的净头寸。

可以，Coinbase 的中心化交易所目前提供 Injective。有关更详细的说明，请查看我们实用的如何购买Injective指南。